Publications by authors named "Josep M Piulats"

27Publications

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.

Eur Urol 2020 Nov 2. Epub 2020 Nov 2.

Program of Molecular Mechanisms and Experimental Therapeutics in Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Gran Via de L'Hospitalet, Barcelona, Spain; Program Against Cancer Therapeutics Resistance (ProCURE), Catalan Institute of Oncology, Gran Via de L'Hospitalet, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2020.10.001DOI Listing
November 2020

Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials.

J Peripher Nerv Syst 2020 06 24;25(2):171-177. Epub 2020 Mar 24.

Department of Medicine, Division Oncology, Medical School, University Hospital of Patras, Rion-Patras, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jns.12371DOI Listing
June 2020

A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.

Clin Cancer Res 2018 08 17;24(15):3717-3728. Epub 2018 Apr 17.

Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3509DOI Listing
August 2018

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).

J Clin Oncol 2018 04 12;36(12):1232-1239. Epub 2018 Mar 12.

Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center; Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY; Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris; Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France; Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands; Stephen Frank, Hebrew University Hadassah Medical School - The Sharett Institute of Oncology, Jerusalem; Jacob Schachter, Sheba Medical Center at Tel Hashomer, and Tel-Aviv University Medical School, Tel Aviv, Israel; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Josep M. Piulats, Institut Catala d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain; Pascal Wolter, University Hospitals Leuven, Leuven, Belgium; Veronique Cocquyt, Ghent University Hospital, Ghent, Belgium; Bartosz Chmielowski, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA; T.R. Jeffry Evans, University of Glasgow, Glasgow; Delyth Clemett, Shirley Spratt, Susan Lovick, and Elaine Kilgour, AstraZeneca, Macclesfield; Dana Ghiorghiu and Gabriella Mariani, AstraZeneca, Cambridge; Paul Nathan, Mt Vernon Cancer Centre, Northwood, United Kingdom; Gerald Linette, Washington University School of Medicine, St Louis, MO; Carola Berking, University Hospital of Munich, Munich, Germany; Peter Barker, AstraZeneca, Gaithersburg, MD; and Zhongwu Lai, AstraZeneca, Waltham, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1090DOI Listing
April 2018

TGFβ Controls Ovarian Cancer Cell Proliferation.

Int J Mol Sci 2017 Jul 30;18(8). Epub 2017 Jul 30.

Program Against Cancer Therapeutic Resistance (ProCURE), Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms18081658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578048PMC
July 2017

Molecular approaches for classifying endometrial carcinoma.

Gynecol Oncol 2017 04 29;145(1):200-207. Epub 2016 Dec 29.

Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLLEIDA, Lleida, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258163168
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2016.12.015DOI Listing
April 2017

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

J Clin Oncol 2017 Jan 31;35(1):40-47. Epub 2016 Oct 31.

Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia; Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland; Josep M. Piulats, Institut Català d'Oncologia, Barcelona; Javier Puente, Hospital Clínico San Carlos, Madrid, Spain; Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar; Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile; Dirk Jaeger, University Hospital, Heidelberg, Germany; Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil; Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico; Lisa Sengeløv, Herlev Hospital, Herlev, Denmark; M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT; Arvind Varma, DOCS Inc, New York, NY; Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam; and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.1584DOI Listing
January 2017

Uveal melanoma as a target for immune-therapy.

Ann Transl Med 2016 May;4(9):172

Department of Medical Oncology, Genitourinary, Melanoma and Sarcoma Unit, Institut Català d'Oncologia, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.05.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876283PMC
May 2016

INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.

Retina 2015 Sep;35(9):1890-7

*Department of Ophthalmology, Ocular Oncology and Vitreoretinal Service, University Hospital of Bellvitge, Barcelona, Spain; Departments of †Brachytherapy, and ‡Oncology, Catalan Institute of Oncology, Barcelona, Spain; and §Department of Ophthalmology, Vitreoretinal Service, Hospital Clinic of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/retinajournal/2015/09000/INTRAV
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IAE.0000000000000537DOI Listing
September 2015

Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer.

Clin Cancer Res 2014 04 17;20(7):1925-34. Epub 2014 Feb 17.

Authors' Affiliations: Royal Marsden NHS Foundation Trust and The Institute of Cancer Research UK, Sutton; Institut Català d'Oncologia, L'Hospitalet, Barcelona; University of Surrey, Surrey, United Kingdom; Yale University Cancer Center, New Haven; Centre Hospitalier de l'Universite de Montreal, Montreal; A Coruña University Hospital, A Coruña, Spain; Kantonsspital St. Gallen, St. Gallen, Switzerland; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Pfizer Inc, Groton, Connecticut; and Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1869DOI Listing
April 2014

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.

BMC Cancer 2013 Aug 10;13:382. Epub 2013 Aug 10.

Laboratori de Recerca Translacional, Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, 08908, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751347PMC
August 2013

Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.

Am J Ophthalmol 2013 Aug 13;156(2):334-342.e1. Epub 2013 May 13.

Ophthalmology Department, University Hospital of Bellvitge, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2013.03.036DOI Listing
August 2013

Epigenetic disruption of cadherin-11 in human cancer metastasis.

J Pathol 2012 Oct 26;228(2):230-40. Epub 2012 Jul 26.

Cancer Epigenetics and Biology Programme (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467766PMC
October 2012

Uveal melanoma and BRCA1/BRCA2 genes: a relationship that needs further investigation.

J Clin Oncol 2011 Dec 24;29(34):e827-9. Epub 2011 Oct 24.

Medical Oncology Department, Institut Català d'Oncologia, Avda Gran Via No 199-203, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.37.8828DOI Listing
December 2011